GigaGen Expands Contract With US Department of Defense for Synthetic Antibody Treatments for Botulinum Neurotoxins

URLhttps://www.infectioncontroltoday.com/view/gigagen
SourceInfection Control Today
Date Published11/27/2023

Additional Reshoring Information:

Company/Division name GigaGen
Type of work Manufacturing
Reshoring category:Reshoring
Year reshoring announced:2023
Domestically, the work will be done:In-house
Capital investment ($):11.8
City reshored to:San Francisco
State(s) reshored to:CA
If relevant, work nearshored to:-
Industry(ies):Chemicals
Product(s) reshoredantibodies
What domestic positive factors made reshoring more attractive?Government Incentives, Govt. Policy and subsidies
Government Incentive dollar amount:$11.8 million contract DoD
Find Reshoring Articles